Sample-efficient generative molecular design using memory manipulation

2026-03-17 · Source: Nature Machine Intelligence · Field: Technology & Digital — Artificial Intelligence & Machine Learning, Emerging Technologies & Innovation · Depth: Expert, long

Summary

A novel framework named Saturn, which applies the Mamba architecture to generative molecular design, significantly improves sample efficiency for drug discovery. This approach addresses the critical challenge of directly optimizing molecules using high-fidelity, computationally expensive oracles like Density Functional Theory (DFT) simulations, a task current models are not efficient enough to handle. Saturn integrates "experience replay with data augmentation," a mechanism whose effect is intensified by the Mamba architecture, enabling it to outperform 16 other models on multiparameter optimization tasks. Crucially, Saturn demonstrates sufficient sample efficiency to directly optimize at the DFT fidelity level with an oracle budget of 500, promising enhanced generative design and improved hit rates in drug discovery. The datasets (ChEMBL 33, ZINC 250k), pretrained models, and codebase are publicly available for reproduction.

Key takeaway

The Saturn framework introduces a Mamba architecture with experience replay and data augmentation for generative molecular design, significantly improving sample efficiency and outperforming 16 models on multiparameter optimization tasks. This enables direct optimization using high-fidelity Density Functional Theory (DFT) simulations, making accurate but computationally expensive oracle evaluations practical for accelerating drug discovery hit rates.

Topics

• Generative Molecular Design
• Mamba Architecture
• Sample Efficiency
• Drug Discovery
• Density Functional Theory

Code references

• SeulLee05/GEAM
• schwallergroup/saturn

Best for: Research Scientist, AI Researcher, AI Scientist, Machine Learning Engineer

Related on AIssential

• Tevogen Bio’s Journey to Streamlining Life-Saving Therapies — Integrating a data lakehouse architecture with ML significantly accelerates drug discovery target identification.
• Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Design — Probing molecular edit responses guides LLM agents to jointly optimize binding affinity and druggability in drug design.
• AgForce Enables Antigen-conditioned Generative Antibody Design — Existing antibody design models fail to condition on antigen, suffering from antigen blindness and vocabulary collapse due to cross-entropy loss.
• Active Flow Expansion for Out-of-Distribution Discovery: from Theory to Molecules — Generative models should expand their "generable set" to discover new-to-nature designs beyond training data.
• A generative artificial intelligence approach for peptide antibiotic optimization — ApexGO uses generative AI and Bayesian optimization to efficiently design and optimize peptide antibiotics from existing templates.
• Foundations of Molecular Generation with GP-MoLFormer on AMD Instinct MI300X Accelerators — GP-MoLFormer enables efficient, large-scale molecular generation using sequence-based language models on AMD GPUs.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Nature Machine Intelligence.